Steven Cohen F Star Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.18 - $6.39 $1.65 Million - $4.85 Million	-758,239 Reduced 89.2%	91,761 $574,000
Q1 2022 May 16, 2022	SELL	$2.77 - $5.36 $363,559 - $703,494	-131,249 Reduced 13.38%	850,000 $3.02 Million
Q3 2021 Nov 15, 2021	SELL	$5.2 - $8.42 $487,505 - $789,383	-93,751 Reduced 8.72%	981,249 $7.18 Million
Q2 2021 Aug 16, 2021	BUY	$6.57 - $10.71 $6.57 Million - $10.7 Million	1,000,000 Added 1333.33%	1,075,000 $9.23 Million
Q1 2021 May 17, 2021	BUY	$7.09 - $13.84 $531,750 - $1.04 Million	75,000 New	75,000 $812,000

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.